+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Surgical Sutures market set to grow to $6.4bn by 2024” says new Visiongain report

08 October 2019
Pharma

Visiongain has published a new pharma report Global Surgical Sutures Market Report: Absorbable Sutures, Non-Absorbable Sutures, Automated Suturing Devices, General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynaecological Surgery, Ophthalmic Surgery, Facial, Cosmetic & Plastic Surgery.

The global surgical sutures market is expected to reach $6.4bn in 2024 and is estimated to grow at a CAGR of 5.1% from 2019-2024. The Absorbable Sutures submarket held 52% of the global surgical sutures market in 2019.The global anaesthesia drugs market is projected to grow at lucrative rate during the forecast period owing to a rising number of surgical procedures globally, developing healthcare infrastructure in emerging economies, and growing number of geriatric population.

This report profiled the selected companies: AD Surgical, B. Braun Melsungen AG, Bioline Fios Cirúrgicos Ltda, CP Medical, DemeTech Corporation, Ethicon, Inc., Internacional Farmacéutica, Medtronic Plc, Péters Surgical, Riverpoint Medical and other companies.

The lead analyst commented that "The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the market growth."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Antibiotics Market Report 2023-2033

The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.

31 January 2023

Read

Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033

The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.

31 January 2023

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033

The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.

31 January 2023

Read

Visiongain Publishes Human Microbiome Market Report 2023-2033

The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

30 January 2023

Read